144 related articles for article (PubMed ID: 17920138)
1. Cystatin B and its EPM1 mutants are polymeric and aggregate prone in vivo.
Cipollini E; Riccio M; Di Giaimo R; Dal Piaz F; Pulice G; Catania S; Caldarelli I; Dembic M; Santi S; Melli M
Biochim Biophys Acta; 2008 Feb; 1783(2):312-22. PubMed ID: 17920138
[TBL] [Abstract][Full Text] [Related]
2. Gain in toxic function of stefin B EPM1 mutants aggregates: correlation between cell death, aggregate number/size and oxidative stress.
Polajnar M; Zavašnik-Bergant T; Kopitar-Jerala N; Tušek-Žnidarič M; Zerovnik E
Biochim Biophys Acta; 2014 Sep; 1843(9):2089-99. PubMed ID: 24909779
[TBL] [Abstract][Full Text] [Related]
3. Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations.
Alakurtti K; Weber E; Rinne R; Theil G; de Haan GJ; Lindhout D; Salmikangas P; Saukko P; Lahtinen U; Lehesjoki AE
Eur J Hum Genet; 2005 Feb; 13(2):208-15. PubMed ID: 15483648
[TBL] [Abstract][Full Text] [Related]
4. Insights in progressive myoclonus epilepsy: HSP70 promotes cystatin B polymerization.
Rispoli A; Cipollini E; Catania S; Di Giaimo R; Pulice G; van Houte S; Sparla F; Dal Piaz F; Roncarati D; Trost P; Melli M
Biochim Biophys Acta; 2013 Dec; 1834(12):2591-9. PubMed ID: 24063889
[TBL] [Abstract][Full Text] [Related]
5. Influence of partial unfolding and aggregation of human stefin B (cystatin B) EPM1 mutants G50E and Q71P on selective cleavages by cathepsins B and S.
Polajnar M; Vidmar R; Vizovišek M; Fonović M; Kopitar-Jerala N; Žerovnik E
Biol Chem; 2013 Jun; 394(6):783-90. PubMed ID: 23362198
[TBL] [Abstract][Full Text] [Related]
6. Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1).
Lalioti MD; Mirotsou M; Buresi C; Peitsch MC; Rossier C; Ouazzani R; Baldy-Moulinier M; Bottani A; Malafosse A; Antonarakis SE
Am J Hum Genet; 1997 Feb; 60(2):342-51. PubMed ID: 9012407
[TBL] [Abstract][Full Text] [Related]
7. In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1.
Rabzelj S; Turk V; Zerovnik E
Protein Sci; 2005 Oct; 14(10):2713-22. PubMed ID: 16155205
[TBL] [Abstract][Full Text] [Related]
8. New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B.
Di Giaimo R; Riccio M; Santi S; Galeotti C; Ambrosetti DC; Melli M
Hum Mol Genet; 2002 Nov; 11(23):2941-50. PubMed ID: 12393805
[TBL] [Abstract][Full Text] [Related]
9. Reduced serotonin and 3-hydroxyanthranilic acid levels in serum of cystatin B-deficient mice, a model system for progressive myoclonus epilepsy.
Arbatova J; D'Amato E; Vaarmann A; Zharkovsky A; Reeben M
Epilepsia; 2005; 46 Suppl 5():49-51. PubMed ID: 15987253
[TBL] [Abstract][Full Text] [Related]
10. Generation of a human induced pluripotent stem cell line (UEFi004-A) from a patient with progressive myoclonic epilepsy type 1 (EPM1).
Singh S; Plotnikova L; Karvonen K; Ryytty S; Hyppönen J; Kälviäinen R; Hämäläinen RH
Stem Cell Res; 2023 Dec; 73():103248. PubMed ID: 37951142
[TBL] [Abstract][Full Text] [Related]
11. [From gene to disease; progressive myoclonus epilepsy of Unverricht-Lundborg and mutations in the cystatin B gene].
de Haan GJ; Halley DJ; Deelen WH; Lindhout D
Ned Tijdschr Geneeskd; 2002 May; 146(18):846-8. PubMed ID: 12038222
[TBL] [Abstract][Full Text] [Related]
12. Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1.
Lehtinen MK; Tegelberg S; Schipper H; Su H; Zukor H; Manninen O; Kopra O; Joensuu T; Hakala P; Bonni A; Lehesjoki AE
J Neurosci; 2009 May; 29(18):5910-5. PubMed ID: 19420257
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of the mouse cystatin B gene.
Pennacchio LA; Myers RM
Genome Res; 1996 Nov; 6(11):1103-9. PubMed ID: 8938434
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy.
Kaur G; Mohan P; Pawlik M; DeRosa S; Fajiculay J; Che S; Grubb A; Ginsberg SD; Nixon RA; Levy E
Am J Pathol; 2010 Nov; 177(5):2256-67. PubMed ID: 20889561
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1).
Pennacchio LA; Lehesjoki AE; Stone NE; Willour VL; Virtaneva K; Miao J; D'Amato E; Ramirez L; Faham M; Koskiniemi M; Warrington JA; Norio R; de la Chapelle A; Cox DR; Myers RM
Science; 1996 Mar; 271(5256):1731-4. PubMed ID: 8596935
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1).
Riccio M; Di Giaimo R; Pianetti S; Palmieri PP; Melli M; Santi S
Exp Cell Res; 2001 Jan; 262(2):84-94. PubMed ID: 11139332
[TBL] [Abstract][Full Text] [Related]
17. Altered spacing of promoter elements due to the dodecamer repeat expansion contributes to reduced expression of the cystatin B gene in EPM1.
Lalioti MD; Scott HS; Antonarakis SE
Hum Mol Genet; 1999 Sep; 8(9):1791-8. PubMed ID: 10441345
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the cystatin B gene promoter harboring the dodecamer repeat expanded in progressive myoclonus epilepsy, EPM1.
Alakurtti K; Virtaneva K; Joensuu T; Palvimo JJ; Lehesjoki AE
Gene; 2000 Jan; 242(1-2):65-73. PubMed ID: 10721698
[TBL] [Abstract][Full Text] [Related]
19. Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy.
Rinne R; Saukko P; Järvinen M; Lehesjoki AE
Ann Med; 2002; 34(5):380-5. PubMed ID: 12452481
[TBL] [Abstract][Full Text] [Related]
20. Intramolecular i-motif structure at acidic pH for progressive myoclonus epilepsy (EPM1) repeat d(CCCCGCCCCGCG)n.
Pataskar SS; Dash D; Brahmachari SK
J Biomol Struct Dyn; 2001 Oct; 19(2):307-13. PubMed ID: 11697735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
